Phenomics Health Inc
June 17, 2025
Company Presentation

Phenomics Health™ is the first precision medicine company to personalize drug treatment by predicting the optimal medication and dose for each patient. We combine drug level measurement with tools to assess polypharmacy, drug-drug interactions, and adherence. Our CLIA-certified lab integrates data from pharmacometabolomics, long-read sequencing, polygenic risk scores, and clinical records from biobanks like the Michigan Genomics Initiative to power a proprietary Foundation Model. This model identifies patients at high risk due to complex medication regimens and comorbidities. Phenomics Health acts as a virtual second opinion for difficult cases—enhancing safety, reducing adverse events, and improving outcomes, while minimizing financial and legal risk. Our platform is also used in clinical trials for patient-trial matching, safety analytics, and AI-powered multi-omic insights for drug discovery.

Company HQ City:
Plymouth
Company HQ State:
MI
Company HQ Country:
United States
Year Founded:
2018
Lead Product in Development:
Phenomics AI
CEO
Daniel Jasewicz
Development Phase of Lead Product
Other/Not Applicable
Number of Unlicensed Products Looking for Licensing
Multiple Products in Pharmacogenomics and Pharmacometabolomics
When you expect your next catalyst update?
Series B
What is your next catalyst (value inflection) update?
Q1 2026
Primary Speaker